NPI: 1871534297 · RICHLANDS, VA 24641 · General Acute Care Hospital · NPI assigned 06/09/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 06/09/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 110,496 | $2.23M |
| 2019 | 137,432 | $3.63M |
| 2020 | 115,910 | $3.51M |
| 2021 | 132,099 | $3.86M |
| 2022 | 129,718 | $4.06M |
| 2023 | 139,822 | $4.91M |
| 2024 | 111,822 | $4.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 22,666 | 19,397 | $3.27M |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,471 | 7,251 | $2.13M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,778 | 12,881 | $2.00M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,458 | 7,794 | $1.33M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,517 | 4,931 | $1.04M |
| 41899 | Unlisted procedure, dentoalveolar structures | 590 | 553 | $960K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,577 | 1,395 | $864K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,961 | 2,695 | $821K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,950 | 1,755 | $771K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,007 | 4,806 | $699K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,735 | 3,266 | $640K |
| 11043 | 2,725 | 1,437 | $629K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,445 | 1,301 | $570K |
| G0378 | Hospital observation service, per hour | 8,087 | 4,101 | $511K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,498 | 1,216 | $476K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,046 | 1,435 | $426K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,171 | 2,901 | $411K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,142 | 1,876 | $401K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,324 | 3,016 | $398K |
| 80053 | Comprehensive metabolic panel | 47,108 | 36,656 | $346K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9,710 | 2,663 | $282K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,819 | 2,934 | $241K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,252 | 1,097 | $214K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 51,055 | 37,243 | $212K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,962 | 1,594 | $201K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,728 | 1,615 | $190K |
| 71250 | 2,472 | 2,181 | $173K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,674 | 1,543 | $170K |
| 93017 | 1,884 | 1,684 | $159K | |
| 97032 | 3,474 | 965 | $152K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,667 | 1,488 | $138K |
| 84443 | Thyroid stimulating hormone (TSH) | 19,884 | 17,488 | $136K |
| 96367 | 2,662 | 1,465 | $134K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6,496 | 6,006 | $132K |
| 29581 | 1,083 | 366 | $123K | |
| 80061 | Lipid panel | 13,345 | 12,199 | $123K |
| 95886 | 589 | 548 | $118K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,997 | 6,183 | $109K |
| 74178 | 574 | 515 | $109K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,623 | 1,264 | $108K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 604 | 547 | $104K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17,666 | 13,762 | $103K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,436 | 2,303 | $97K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,882 | 1,611 | $96K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 4,782 | 4,379 | $95K |
| 81001 | 21,467 | 17,757 | $92K | |
| 80306 | 6,617 | 5,584 | $88K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,740 | 4,238 | $87K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,506 | 6,595 | $87K |
| 71046 | Radiologic examination, chest; 2 views | 5,044 | 4,424 | $87K |
| 93970 | 831 | 746 | $85K | |
| 86803 | 1,889 | 1,778 | $84K | |
| 86003 | 1,911 | 1,802 | $78K | |
| 82607 | 4,021 | 3,691 | $77K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,195 | 3,012 | $73K |
| 82728 | 4,843 | 4,394 | $73K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4,605 | 3,871 | $72K |
| 83036 | Hemoglobin; glycosylated (A1C) | 10,942 | 10,050 | $70K |
| 97161 | 438 | 419 | $69K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,535 | 10,672 | $67K |
| 87522 | Neg quan hep c or qual rna | 1,812 | 1,684 | $63K |
| 80076 | 2,453 | 2,076 | $61K | |
| 93971 | 725 | 635 | $60K | |
| J1453 | Injection, fosaprepitant, 1 mg | 795 | 454 | $59K |
| 36415 | Collection of venous blood by venipuncture | 44,888 | 32,267 | $59K |
| 96375 | Therapeutic injection; each additional sequential IV push | 13,371 | 8,157 | $58K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 89 | 79 | $57K |
| 84439 | 5,868 | 5,377 | $55K | |
| 76536 | 538 | 506 | $54K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,707 | 693 | $54K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,572 | 3,293 | $53K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 28 | 25 | $50K |
| 83880 | 4,890 | 4,010 | $49K | |
| 96523 | 783 | 667 | $48K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,571 | 3,290 | $45K |
| 87040 | 5,156 | 3,718 | $44K | |
| 83550 | 4,531 | 4,132 | $43K | |
| 83655 | 2,591 | 2,494 | $42K | |
| 73564 | 2,095 | 1,861 | $40K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 630 | 562 | $39K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,062 | 937 | $38K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,051 | 960 | $38K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 364 | 285 | $38K |
| 72110 | 1,313 | 1,201 | $38K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 374 | 240 | $35K |
| 87902 | 407 | 358 | $35K | |
| 87077 | 6,059 | 5,199 | $34K | |
| 84702 | 2,480 | 2,060 | $34K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 872 | 747 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,150 | 1,095 | $31K |
| 84145 | 5,023 | 4,144 | $31K | |
| 73630 | 1,733 | 1,555 | $31K | |
| 80074 | 1,478 | 1,369 | $28K | |
| 93880 | 389 | 347 | $27K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 96 | 90 | $26K |
| 71045 | Radiologic examination, chest; single view | 10,363 | 8,418 | $26K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 43 | 38 | $25K |
| 73610 | 1,582 | 1,409 | $25K | |
| 82785 | 1,638 | 1,563 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,457 | 7,579 | $24K |
| 73030 | 1,224 | 1,118 | $23K | |
| 87186 | 5,838 | 4,879 | $22K | |
| 94726 | 539 | 494 | $22K | |
| 83540 | 4,637 | 4,226 | $22K | |
| 74018 | 868 | 699 | $21K | |
| 84484 | 11,235 | 7,580 | $21K | |
| 94375 | 557 | 510 | $20K | |
| 85379 | 4,758 | 4,098 | $20K | |
| 78227 | 69 | 64 | $20K | |
| 83735 | 10,827 | 7,873 | $19K | |
| 77080 | 341 | 311 | $19K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 456 | 438 | $18K |
| 80050 | General health panel | 43 | 43 | $17K |
| 94200 | 541 | 495 | $17K | |
| 72131 | 242 | 222 | $16K | |
| 73130 | 787 | 704 | $16K | |
| 85610 | 10,631 | 8,448 | $16K | |
| 82570 | 1,545 | 1,342 | $15K | |
| 87070 | 3,149 | 2,696 | $15K | |
| 85652 | 2,218 | 1,813 | $14K | |
| 84402 | 983 | 887 | $14K | |
| J7050 | Infusion, normal saline solution, 250 cc | 12,689 | 8,351 | $14K |
| 73110 | 742 | 639 | $14K | |
| 76642 | 104 | 93 | $12K | |
| 97162 | 554 | 494 | $12K | |
| 76641 | 91 | 87 | $12K | |
| 84403 | 921 | 827 | $12K | |
| 86038 | 558 | 500 | $11K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 28 | 24 | $11K |
| 83605 | 6,909 | 5,555 | $10K | |
| 94729 | 483 | 438 | $10K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,592 | 1,404 | $10K |
| 84550 | 734 | 581 | $10K | |
| 82043 | 2,483 | 2,226 | $10K | |
| 83690 | 7,857 | 6,571 | $10K | |
| 82962 | 10,917 | 5,836 | $10K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 57 | 51 | $10K |
| 82150 | 3,180 | 2,765 | $9K | |
| 82565 | 2,212 | 1,732 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,947 | 10,657 | $9K |
| 86738 | 1,240 | 1,081 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 13,078 | 9,696 | $9K |
| 84153 | 977 | 870 | $8K | |
| 90715 | 536 | 499 | $8K | |
| 84100 | 3,679 | 2,796 | $8K | |
| 82746 | 930 | 854 | $8K | |
| 86140 | 1,895 | 1,645 | $8K | |
| 84481 | 596 | 546 | $8K | |
| 80081 | 505 | 485 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 790 | 739 | $7K |
| 84703 | 3,793 | 3,407 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,252 | 6,482 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 662 | 570 | $7K |
| 88342 | 1,282 | 1,178 | $7K | |
| 83001 | 252 | 239 | $7K | |
| 96415 | 27 | 15 | $7K | |
| 82677 | 349 | 333 | $7K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 70 | 54 | $6K |
| 84436 | 220 | 195 | $6K | |
| 88304 | 573 | 526 | $6K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 7,302 | 6,477 | $6K |
| 87507 | 234 | 207 | $6K | |
| 87205 | 3,034 | 2,575 | $6K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 66 | 64 | $6K |
| 78451 | 36 | 28 | $6K | |
| 73502 | 348 | 311 | $6K | |
| 82784 | 479 | 427 | $6K | |
| 87631 | 216 | 205 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 790 | 726 | $6K |
| 76937 | 147 | 126 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 64 | 62 | $5K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 62 | 48 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,735 | 4,805 | $5K |
| 93225 | 139 | 129 | $5K | |
| 95911 | 195 | 183 | $5K | |
| 85027 | 379 | 353 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,940 | 7,631 | $5K |
| 82550 | 376 | 313 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 13,190 | 10,207 | $5K |
| 78226 | 13 | 12 | $5K | |
| J2704 | Injection, propofol, 10 mg | 7,606 | 6,931 | $5K |
| J2785 | Injection, regadenoson, 0.1 mg | 1,078 | 963 | $4K |
| 85730 | 6,470 | 5,465 | $4K | |
| 96368 | 580 | 355 | $4K | |
| 81025 | 4,189 | 3,810 | $4K | |
| 81596 | 62 | 54 | $4K | |
| 10060 | 12 | 12 | $4K | |
| 87505 | 89 | 85 | $4K | |
| 86141 | 1,524 | 1,314 | $3K | |
| 86336 | 347 | 331 | $3K | |
| 82805 | 737 | 548 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 121 | 109 | $3K |
| 29125 | 18 | 16 | $3K | |
| 86850 | 900 | 774 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 358 | 345 | $3K |
| 76770 | 25 | 25 | $3K | |
| 82947 | 318 | 304 | $3K | |
| 82977 | 229 | 210 | $3K | |
| 29799 | 15 | 15 | $3K | |
| 87486 | 494 | 428 | $3K | |
| 87481 | 148 | 127 | $3K | |
| 86800 | 187 | 179 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,191 | 2,399 | $3K |
| 93226 | 139 | 129 | $3K | |
| 87150 | 346 | 320 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 241 | 207 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,286 | 4,710 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,423 | 3,140 | $2K |
| 86901 | 1,461 | 1,244 | $2K | |
| 93246 | 75 | 61 | $2K | |
| 87529 | 165 | 142 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,801 | 8,664 | $2K |
| 84146 | 45 | 37 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7,100 | 5,305 | $2K |
| 86431 | 470 | 429 | $2K | |
| 87581 | 494 | 428 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,472 | 5,851 | $2K |
| 85014 | 256 | 226 | $2K | |
| 83615 | 244 | 212 | $2K | |
| 86900 | 1,470 | 1,252 | $2K | |
| 88312 | 556 | 488 | $2K | |
| 72050 | 46 | 42 | $2K | |
| 84681 | 38 | 38 | $2K | |
| J3490 | Unclassified drugs | 270 | 184 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 70 | 58 | $2K |
| 96376 | 2,683 | 1,671 | $2K | |
| 80171 | 180 | 161 | $2K | |
| 85018 | 289 | 249 | $2K | |
| 86317 | 67 | 63 | $1K | |
| 76870 | 14 | 13 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 547 | 344 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,300 | 2,554 | $1K |
| 93922 | 15 | 13 | $1K | |
| 95912 | 14 | 13 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 108 | 93 | $1K |
| 74246 | 14 | 14 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,248 | 1,946 | $1K |
| 82140 | 392 | 313 | $1K | |
| 83516 | 32 | 30 | $1K | |
| 87340 | 107 | 101 | $1K | |
| 77066 | Tomosynthesis, mammo | 64 | 55 | $1K |
| 86592 | 122 | 112 | $1K | |
| 83002 | 37 | 36 | $1K | |
| 86235 | 27 | 27 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 26 | 24 | $1K |
| 86677 | 124 | 105 | $1K | |
| 86225 | 71 | 67 | $985.82 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,908 | 2,596 | $912.50 |
| 36600 | 622 | 470 | $897.23 | |
| 86704 | 65 | 61 | $867.31 | |
| 73080 | 73 | 65 | $849.97 | |
| 86200 | 148 | 135 | $769.33 | |
| 87338 | 34 | 31 | $737.87 | |
| J2805 | Injection, sincalide, 5 micrograms | 13 | 12 | $721.83 |
| 87506 | 17 | 15 | $720.22 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 56 | 50 | $600.74 |
| 97035 | 33 | 12 | $592.05 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,950 | 2,408 | $571.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,763 | 2,517 | $529.74 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 248 | 237 | $488.59 |
| 0002A | 13 | 13 | $484.24 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 3,014 | 2,732 | $480.87 |
| 74248 | 12 | 12 | $458.31 | |
| 0001A | 29 | 29 | $451.70 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 964 | 898 | $448.33 |
| 73590 | 58 | 53 | $448.22 | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,621 | 1,745 | $440.22 |
| S9470 | Nutritional counseling, dietitian visit | 104 | 99 | $423.04 |
| J1940 | Injection, furosemide, up to 20 mg | 930 | 668 | $415.04 |
| 83010 | 70 | 67 | $409.84 | |
| 82105 | 30 | 27 | $403.71 | |
| 84450 | 114 | 109 | $399.14 | |
| 86708 | 16 | 16 | $384.19 | |
| 84460 | 126 | 121 | $363.07 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,890 | 1,454 | $358.70 |
| G0379 | Direct admission of patient for hospital observation care | 62 | 49 | $355.46 |
| 86665 | 27 | 25 | $348.99 | |
| 86376 | 37 | 37 | $339.18 | |
| 83525 | 31 | 28 | $332.74 | |
| 82172 | 37 | 36 | $312.10 | |
| 95913 | 46 | 42 | $311.88 | |
| 82248 | 44 | 39 | $306.38 | |
| 86231 | 55 | 54 | $291.35 | |
| 84478 | 66 | 63 | $282.42 | |
| 87177 | 41 | 39 | $280.82 | |
| 82652 | 25 | 25 | $280.03 | |
| 87807 | 663 | 628 | $264.64 | |
| 99152 | 249 | 208 | $259.10 | |
| 88300 | 108 | 100 | $255.40 | |
| 86364 | 76 | 68 | $254.64 | |
| 86258 | 76 | 68 | $254.64 | |
| J1956 | Injection, levofloxacin, 250 mg | 470 | 344 | $253.38 |
| 36591 | 13 | 12 | $250.31 | |
| 87329 | 41 | 39 | $246.66 | |
| 82247 | 76 | 69 | $188.78 | |
| 90686 | 14 | 12 | $176.81 | |
| 82465 | 38 | 37 | $172.04 | |
| 87045 | 29 | 26 | $170.49 | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 671 | 288 | $166.80 |
| A9270 | Non-covered item or service | 4,292 | 2,342 | $149.35 |
| 96417 | 223 | 155 | $130.86 | |
| 88311 | 12 | 12 | $125.06 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,537 | 1,297 | $101.69 |
| 81003 | 34 | 33 | $98.87 | |
| J2060 | Injection, lorazepam, 2 mg | 812 | 603 | $89.43 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 205 | 61 | $77.57 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 596 | 447 | $72.97 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 689 | 632 | $59.83 |
| J1815 | Injection, insulin, per 5 units | 369 | 238 | $53.84 |
| 87427 | 15 | 14 | $45.22 | |
| 82272 | 63 | 49 | $43.66 | |
| 84156 | 20 | 14 | $36.71 | |
| 86769 | 14 | 13 | $35.59 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 307 | 280 | $32.54 |
| 86308 | 12 | 12 | $31.56 | |
| 87081 | 17 | 16 | $28.14 | |
| 84520 | 30 | 12 | $26.43 | |
| 85049 | 17 | 14 | $21.22 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 142 | 118 | $18.42 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 539 | 503 | $17.75 |
| J8540 | Dexamethasone, oral, 0.25 mg | 44 | 39 | $17.48 |
| 85045 | 12 | 12 | $14.52 | |
| J3480 | Injection, potassium chloride, per 2 meq | 88 | 49 | $14.24 |
| 99153 | Mod sedat endo service >5yrs | 12 | 12 | $11.83 |
| C1769 | Guide wire | 196 | 163 | $11.74 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 133 | 109 | $10.22 |
| J1790 | Injection, droperidol, up to 5 mg | 295 | 269 | $9.43 |
| J1644 | Injection, heparin sodium, per 1000 units | 14 | 14 | $9.05 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 222 | 186 | $4.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 74 | 67 | $2.42 |
| J1630 | Injection, haloperidol, up to 5 mg | 13 | 13 | $2.16 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 35 | 24 | $1.35 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 163 | 149 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 93 | 82 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 90 | 74 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 16 | 13 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 91 | 70 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 16 | 13 | $0.00 |